Keywords: Viscosity-regulating pectin; Semi-solid; Aspiration pneumonia; Diarrhea; Infusion time; REF-P1; AC; arm circumference; Alb; albumin; BMI; body mass index; CRP; C-reactive protein; EN; enteral nutrition; GER; gastroesophageal reflux; IRB; institutional rev
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Newborns; Perfluorinated compounds; Organochlorine pesticides; Polychlorinated biphenyls; Thyroid; ED; endocrine disruptor; TH; thyroid hormone; T4; thyroxine; T3; triiodothyronine; PCB; polychlorinated biphenyl; TTR; transthyretin; TSH; thyroid stimulati
Keywords: AGFI; adjusted goodness of fit index; AMC; antimicrosome antibody; ATG; antithyroglobulin antibody; CFI; comparative fit index; CI; confidence interval; FT4; free thyroxine; GFI; goodness of fit index; IQR; interquartile range; LC/MS/MS; liquid chromatogr
Keywords: AF; atrial fibrillation; CHA2DS2-VASc; congestive heart failure, hypertension, age â¥75 years, diabetes mellitus, stroke/transient ischemic attack, vascular disease, age 65 to 74 years, sex category; HR; hazard ratio; ICD-9; International Classification
Keywords: OAC; Oral anticoagulant; VKA; Vitamin K antagonist; DOAC; Direct oral anticoagulant; PCC; Prothrombin complex concentrate; 4F-PCC; Four factor PCC; 3F-PCC; Three factor PCC; aPCC; Activated PCC; FFP; Fresh frozen plasma; AF; Atrial fibrillation; TE; Throm
Keywords: Sudomotor function; ESC; Skin biopsy; Neuropathic pain; Dysautonomia; ANS; autonomic nervous system; CGRP; calcitonin gene-related peptide; Cy3; cyanine 3.18; ESC; electrochemical skin conductance; IENF; intraepidermal nerve fibre; IENFD; intraepidermal n
Keywords: Therapeutic genome editing; Non-viral delivery; Nuclease-mediated genome editing; Oligonucleotide-mediated genome editing; CRISPR/Cas9; Peptide nucleic acid; BBB; blood brain barrier; CMV; cell-derived membrane vesicle; CRISPR; Clustered Regularly Intersp
Keywords: 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: AUC; area under the curve; BMI; Body Mass Index; BCAA; sum of the branched-chain amino acids valine, isoleucine and leucine; BCKA; sum of the branched-chain keto acids: KIC, KIV and KMV; DXA; dual-energy X-ray absorptiometry; EAA; sum of the amino acids t
Keywords: ALS; Amyotrophic lateral sclerosis; DMD; DuchenneMuscular Dystrophy; SMA; Spinalmuscular atrophy; FAP; FamilialAmyloid Polyneuropathy; OD; Orphandisease; ORD; Officeof Rare Diseases; NIH; NationalInstitutes of Health; sALS; SporadicALS; fALS; FamilialALS;
Keywords: AN; adiponectin; DrkLvl; level of drinking alcohol; ExeLvl; level of regular exercise; hmAN; high-molecular-weight AN; SDR; standard deviation ratio; SDRage; between-age group SDR; SDRreg; between-region SDR; SDRsex; between-sex SDR; SmkLvl; level of ciga
Keywords: Cardiac amyloidosis; Multiple myeloma; TTR; Cardiotoxicity; Proteasome inhibitors; Immunomodulatory drugs;
Keywords: AOR; adjusted odds ratio; CCI; Charlson Comorbidity Index; CI; confidence interval; CPT; Current Procedural Terminology; IVC; inferior vena cava; PTBD; percutaneous transhepatic biliary drainage; TIPS; transjugular intrahepatic portosystemic shunt; TTR; t
Keywords: AF; atrial fibrillation; BWH; Brigham and Women's Hospital; DOACs; direct oral anticoagulants; HULP; Hospital Universitario La Paz; INR; international normalized ratio; IPAH; idiopathic pulmonary arterial hypertension; IQR; interquartilic range; mPAP; mea
Keywords: Transthyretin; TTR; Amyloid; Familial amyloid polyneuropathy; Senile systemic amyloidosis; Thyroid hormone receptors; Structural biology; Structure-based drug design; In silico docking; Inhibitor; Prediction algorithms;
Keywords: Triage; Trauma; Combat casualty; Massive transfusion; Damage control; Echography; ABC-score; Assessment of blood consumption-score; CRAMS-scale; Circulation Respiratory Abdomen Motor and Speech-scale; DCR; Damage control resuscitation; DCS; Damage control
Keywords: FAP; familial amyloid polyneuropathy; logMAR; logarithm of the minimum angle of resolution; TTR; transthyretin;
Keywords: AF; atrial fibrillation; ATT; antithrombotic treatment; CHA2DS2-VASc; congestive heart failure, hypertension, age â¥75 years, diabetes mellitus, stroke or transient ischemic attack, vascular disease, age 65-74 years, female sex category; EORP-AF; EURObse
Keywords: HCC; hepatocellular carcinoma; HBV; hepatitis B virus; FFPE; formalin-fixed paraffin-embedded; IOD; integral optic density; OS; overall survival; TTR; time-to-recurrence; Hepatocellular carcinoma; Caprin1; Overall survival; Time to recurrence; Prognosis;
Keywords: Diabetes mellitus; Antioxidants; Oxygen free radicals; Nitrative stress; Animal; Human; eNOS; endothelial nitric oxide synthase; NOS3; nitric oxide synthase 3; cNOS; constitutive nitric oxide synthase; nNOS; neuronal nitric oxide synthase; iNOS; induced n
Keywords: Brain; Neuron; Thyroid hormone transport; Mct8; Deiodinase; T4; thyroxine; T3; 3,5,3â²-triiodothyronine; TH; thyroid hormones; 3,5-T2; 3,5-diiodothyronine; 3,3â²-T2; 3,3â²-diiodothyronine; 3-T1AM; 3-iodothyronamine; Tbg; thyroxin-binding globuline; Ttr
Keywords: High-fat diet; Melatonin; Obesity; Plasma protein; Proteomics; APOE; apolipoprotein E; A1AT; α1-antiproteinase; CRP; C-reactive protein; FBG; fibrinogen; GPx3; glutathione peroxidase 3; HFD; high-fat diet; MBP-A; mannose-binding protein A; PLG; plasminog
Keywords: MS; mass spectrometry; LC; liquid chromatography; MRM; multiple reaction monitoring; DP; declustering potential; CE; collision energy; apoA1; apolioprotein A-1; RBP4; retinol-binding protein 4; TTR; transthyretin/prealbumin; CO9; complement component 9; C
Keywords: AAA; ATPases associated with diverse cellular activities; 17-AAG; 17-N-allylamino-17-demethoxygeldanamycin; ABC; ATP-binding cassette; ABCE1; ATP binding cassette subfamily E member 1; AD; Alzheimer's disease; AIF; apoptosis inducing factor; Akt; Alpha se
Keywords: OAT; oral anticoagulation therapy; AF; atrial fibrillation; MACE; major adverse cardiac event; INR; international normalized ratio; VKA; vitamin K antagonist; RFCA; radiofrequency catheter ablation; TTR; target therapeutic range; NOACs; new oral anticoagu
Keywords: BCL-2; B-cell lymphoma 2; CA-125; cancer antigen-125; CAFs; cancer-associated fibroblasts; CCL17; chemokine (C-C motif) ligand 17; CCL2; chemokine (C-C motif) ligand 2; CXCL12; chemokine (C-X-C motif) ligand 12; DFS; disease-free survival; DNMT; DNA methy
Keywords: Familial amyloid polyneuropathy; Transthyretin; Questionnaire; Neuropathy Impairment Score; Small-fiber neuropathy; Symptomatic; Biopsy; Amyloidosis; Therapeutic educational program; FAP; familial amyloid polyneuropathy; TTR; transthyretin; SFN-SIQ; small
Keywords: SPs; synthetic pyrethroids; BF; bifenthrin; λ-CH; λ-cyhalothrin; CRH; corticotropin-releasing hormone; TSH; thyroid stimulating hormone; TTR; transthyretin; UGT1ab; uridine diphosphate glucuronosyltransferase; TPO; thyroid peroxidase; TG; thyroglobulin;
Keywords: cardiac amyloidosis; cardiac dysautonomia; cardiac imaging; liver transplantation; transthyretin; AUC; area under curve; CI; confidence interval; ECG; electrocardiogram; H/M; heart-mediastinum ratio; HRRA; heart rate responses to atropine; IQR; interquart
Keywords: Tufting; Composite; Stitching; Through-thickness reinforcement; TTR; Preform; 3D reinforcement;
Keywords: anticoagulation; bleeding risk; stroke prevention; AF; atrial fibrillation; b.i.d.; twice daily; CKD; chronic kidney disease; ESRD; end-stage renal disease; FDA; Food and Drug Administration; NOAC; non-vitamin K antagonist oral anticoagulant; TTR; time i
Keywords: AME; apparent metabolisable energy; Ca; calcium; CAID; coefficient of apparent ileal digestibility; DM; dry matter; GE; gross energy; N; nitrogen; nPP; non-phytate phosphorus; P; phosphorus; PP; phytate phosphorus; Ti; titanium; TTR; total tract retention
Keywords: Neurodegeneration; Amyloid; Transthyretin; Lead discovery; Bis-furans; Abeta; amyloid beta; AD; Alzheimer's disease; ALB; albumin; CAA; cerebral amyloid angiopathy; FAP; familial amyloid polyneuropathy; IEF; isoelectric focusing; ITC; isothermal titration
Keywords: CTR; Constant timing region; ESC; Embryonic stem cell; FISH; Fluorescent in situ hybridization; HP1; heterochromatin protein 1; MaOri; “master” replication origin; MRT; Mean replication timing; TAD; Topological associated domain; TTR; Timing transitio
Keywords: ACC; Anticoagulation Clinics; AF; Atrial Fibrillation; DC; Direct Current; INR; International Normalised Ratio; PHCC; Primary Health Care Centers; TTR; Time in Therapeutic Range; TIA; Transient Ischemic Attack; anticoagulation; primary care; anticoagulati
Keywords: Anti-TPOs; anti-thyroid peroxidase antibodies; HTP; hypothalamic pituitary; LOD; limit of detection; MISA; The Northern Norway Mother-and-Child contaminant Cohort Study; PFASs; poly- and perfluoroalkyl substances; PFDA; perfluorodecanoate; PFDoDA; perfluo
Keywords: AF; atrial fibrillation; APT; antiplatelet therapy; BARC; Bleeding Academic Research Consortium; CHA2DS2-VASc; congestive heart failure, hypertension, age ⥠75 years (doubled), diabetes, stroke (doubled), vascular disease, age 65 to 74 years, sex catego
Keywords: ACEi; angiotensin-converting enzyme inhibitor; AF; atrial fibrillation; A-II; angiotensin-II; ANP; atrial natriuretic peptide; ARB; angiotensin receptor blocker; BP; blood pressure; BMI; body mass index; BNP; brain natriuretic peptide; CaMKII; calmodulin-
Keywords: AF; atrial fibrillation; BMI; body mass index; CI; confidence interval; HDL-C; high-density lipoprotein cholesterol; HR; hazard ratio; INR; international normalized ratio; LDL-C; low-density lipoprotein cholesterol; NOAC; non-vitamin K antagonist oral a
Keywords: GD; genotype-guided dosing; HR; hazard ratio; INR; international normalized ratio; MD; mean difference; RCT; randomized controlled trial; RR; risk ratio; TMD; time to maintenance dose; TTR; time in therapeutic range;
Keywords: TTR; Time in Therapeutic Range; AF; Atrial fibrillation; OR; Odds ratio; CI; Confidence interval; TIA; Transient ischemic attack; SD; Standard deviation; INR; International Normalized Ratio; TTR; Warfarin; Mechanical heart valve prosthesis;
Keywords: INR; international normalised ratio; OAT; oral anticoagulant treatment; AF; atrial fibrillation; DVT; deep venous thrombosis; PE; pulmonary embolism; MI; post myocardial infarction; VKA; vitamin K antagonists; TR; therapeutic range; TTR; Time in therapeut
Keywords: RT; reverse transcriptase; PCR; polymerase chain reaction; TTR; time to result; InfA/B; influenzavirus A/B; RSVA and B; respiratory syncytical virus A and B; PIV-1; parainfluenzavirus 1; CoV-OC43; coronavirus OC43; Rhv/Entero; rhino-/enterovirus; hMPV; hu
Keywords: TTR; transthyretin; FAP; familial amyloidotic polyneuropathy; SSA; senile systemic amyloidosis; AD; Alzheimer's disease; PET; positron emission tomography; Systemic amyloidosis; Localized amyloidosis; Styrylbenzene; Amyloid positron emission tomography (P
Keywords: VTE; venous thromboembolism; VKA; vitamin K antagonist; TTR; time in therapeutic range; PINRR; proportion of INR measurements in range; INR; international normalized ratio; CI; confidence interval; UK; United Kingdom; RCT; randomized controlled trial; ICH
Keywords: TCE; trichloroethylene; OMLDT; occupational medicamentosa-like dermatitis induced by trichloroethylene; TTR; transthyretin; RBP4; retinol binding protein 4; Hp; haptoglobin; SAA; serum amyloid A protein; CLU; clusterin; Apo; apolipoprotein; 2D-DIGE; two d
Keywords: AP-1; jun proto-oncogene; BAI3; brain-specific angiogenesis inhibitor 3; CADM2; cell adhesion molecule 2; CAGE; cap analysis of gene expression; cDNA; DNA complementary to RNA; ChIP; chromatin immunoprecipitation; FGF14; fibroblast growth factor 14; GADD4
Keywords: AF; Atrial fibrillation; OAC; Oral anticoagulant; INR; International normalised ratio; TTR; Time in therapeutic range; NOAC; Novel oral anticoagulant; ARISTOTLE; Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation; AVER
Keywords: ALAS1; δ-aminolevulinate synthase 1; ANGPTL3; angiopoietin-like 3; FVII; factor VII; FXI; factor XI; GCGR; glucagon receptor; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HoFH; homozygous familial hypercholesterolemia; KSP; kinesin spindle prot
Keywords: ACE; angiotensin I converting enzyme; AGT; angiotensinogen; APOE; apolipoprotein E; APP; amyloid beta (A4) precursor protein; AR; androgen receptor; CADASIL; cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy; CST